EGFR and colorectal cancer: In colorectal cancer, the response of EGFR to treatment with cetuximab is dependent on PTEN status, and in PC-3 cells, restoration of PTEN expression improved response to cetuximab-induced apoptosis and the inhibition of cell proliferation [48,49].